| SC 13D/A | 2024-05-28 | NOVARTIS AG | MorphoSys AG | 29,970,913 | 79.6% | EDGAR |
| SC 13D | 2024-04-18 | NOVARTIS AG | MorphoSys AG | 4,360,100 | 11.6% | EDGAR |
| SC 13G | 2024-03-11 | GOLDMAN SACHS GROUP INC | MorphoSys AG | 4,141,089 | 10.8% | EDGAR |
| SC 13G/A | 2024-03-08 | Kynam Capital Management, LP | MorphoSys AG | 4,190,331 | 11.1% | EDGAR |
| SC 13G/A | 2024-02-16 | T. Rowe Price Investment Management, Inc. | MorphoSys AG | 6,431,063 | 4.3% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | MorphoSys AG | 3,690,331 | 9.8% | EDGAR |
| SC 13G | 2024-02-14 | T. Rowe Price Investment Management, Inc. | MorphoSys AG | 6,431,063 | 4.3% | EDGAR |
| SC 13G | 2023-02-14 | T. Rowe Price Investment Management, Inc. | MorphoSys AG | 7,278,098 | 5.3% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | MorphoSys AG | 118,545 | 0.4% | EDGAR |
| SC 13G/A | 2020-10-09 | BlackRock Inc. | MorphoSys AG | 1,636,430 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | MorphoSys AG | 3,109,249 | 9.7% | EDGAR |
| SC 13G | 2020-02-07 | BlackRock Inc. | MorphoSys AG | 2,574,409 | 8.1% | EDGAR |
| SC 13G | 2019-02-13 | FMR LLC | MorphoSys AG | 3,181,597 | 10.0% | EDGAR |